Anika Therapeutics (ANIK) Revenue (2010 - 2026)
Anika Therapeutics (ANIK) revenue from Jun 30, 2010 to Mar 31, 2026. The TTM Anika Therapeutics (ANIK) revenue is $116M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Anika Therapeutics (ANIK) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -0.67% |
| 3 Years TTM | +0.35% |
| 5 Years TTM | -2.11% |
| 10 Years TTM | +1.54% |
| All Time TTM | +7.19% |
Annual Revenue change of Anika Therapeutics (ANIK)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $30M | -73.75% |
| 2025 | $113M | -5.91% |
| 2024 | $120M | -0.73% |
| 2023 | $121M | +6.11% |
| 2022 | $114M | -22.98% |
| 2021 | $148M | +13.28% |
| 2020 | $130M | +13.83% |
| 2019 | $115M | +325.11% |
| 2018 | $27M | -76.23% |
| 2017 | $113M | +9.71% |
| 2016 | $103M | +11.16% |
| 2015 | $93M | -11.93% |
| 2014 | $106M | +40.65% |
| 2013 | $75M | +5.21% |
| 2012 | $71M | +10.16% |
| 2011 | $65M | +16.59% |
| 2010 | $56M | +38.42% |
| 2009 | $40M | N/A |
Comparison Anika Therapeutics (ANIK) five years revenue CAGR with competitors
Anika Therapeutics (ANIK) five years revenue CAGR is -2.11%.